Upregulation of ERK5 in many types of cancer, such as human lung cancer and prostate cancer, exhibited an invasive and migratory phenotype, thus contributing to elevated metastasis capacities (Ramsay et al., 2011; Park et al., 2016). Here, MAPK7 is linked to prostate cancer.